SymGene Focus is a collection of organ-specific NGS panels focused on carefully selected genes and are supported by clinical and biological evidence. Certain genes in the panels are connected with approved drugs in standard care or drugs in clinical trials.
Genetic profiling of these genes is useful for assessing prognoses and guiding treatment of individuals with advanced cancer who have exhausted standard treatment options.
Lung NGS Panel
13 targeted genes including: BRAF, EGFR, MET plus ALK/ROS1 FISH and PD-L1 IHC
In the clinical setting, molecular testing of targeted genes in the tumor is necessary for decisions on the patient’s treatment strategies.
Test Details
Designed for tumor profiling of primary or metastatic cancers.
Assessing the entire coding exons of each gene for substitutions, insertions and deletions less than 50 bp, copy number variants (gene amplifications or homozygous loss).
This test is performed to evaluate for somatic mutations within tumor samples, does not assess for germline alterations within the genes listed.
Healthcare providers with several options for ordering Sygmene for their patients including LabDOX, fax, and phone. Healthcare providers must first complete a test requisition form to start the process. Turn around times average two weeks from the time a specimen is received.
